glutamine and Coagulation Disorders, Blood

glutamine has been researched along with Coagulation Disorders, Blood in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allemand, E; Berti de Marinis, G; Bonamigo, E; Girolami, A1
Furihata, K; Ishida, F; Kitano, K; Kodaira, H; Shimodaira, S; Takamiya, O1
Charbonnier, B; Delahousse, B; Fimbel, B; Gruel, Y; Iochmann, S; Pouplard, C1
Griffin, JH; Petäjä, JM1
Devivo, DC; Keating, JP1
Eriksson, O; Hoffman, KJ; Ljunggren, C; Lorand, L; Lundén, R; Nilsson, JL; Stenberg, P1

Reviews

1 review(s) available for glutamine and Coagulation Disorders, Blood

ArticleYear
Reye's syndrome.
    Advances in pediatrics, 1976, Volume: 22

    Topics: Ammonia; Blood Coagulation Disorders; Brain; Brain Diseases; Child; Clinical Enzyme Tests; Electroencephalography; Epilepsies, Partial; Female; Glutamine; Humans; Kidney; Liver; Male; Mental Processes; Metabolic Diseases; Myocardium; Pseudotumor Cerebri; Reye Syndrome; Toxemia; Virus Diseases

1976

Other Studies

5 other study(ies) available for glutamine and Coagulation Disorders, Blood

ArticleYear
Worldwide diffusion of FVII Arg304Gln coagulation defect (FVII Padua).
    European journal of haematology, 2011, Volume: 86, Issue:2

    Topics: Animals; Arginine; Blood Coagulation Disorders; Cattle; Factor VII; Factor VII Deficiency; Female; Global Health; Glutamine; Homozygote; Humans; Male; Mutation; Placenta; Pregnancy; Rabbits

2011
Resistance to activated protein C and Arg 506 Gln factor V mutation are uncommon in eastern Asian populations.
    Acta haematologica, 1997, Volume: 98, Issue:1

    Topics: Adult; Aged; Arginine; Blood Coagulation Disorders; China; Drug Resistance; Factor V; Female; Glutamine; Humans; Japan; Korea; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Protein C

1997
Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1997, Volume: 8, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Blood Coagulation Disorders; Case-Control Studies; Child; Factor V; Factor V Deficiency; Female; Glutamine; Heterozygote; Homozygote; Humans; Male; Middle Aged; Pedigree; Point Mutation; Protein C

1997
Activated protein C resistance: What have we learned now that the dust has settled?
    Annals of medicine, 1997, Volume: 29, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation Disorders; Cerebrovascular Disorders; Drug Resistance; Factor V; Female; Glutamine; Humans; Male; Middle Aged; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophlebitis; Thrombosis

1997
Fibrin-stabilizing factor inhibitors.
    Annals of the New York Academy of Sciences, 1972, Dec-08, Volume: 202

    Topics: Amines; Binding Sites; Blood Coagulation; Blood Coagulation Disorders; Cadaverine; Chemical Phenomena; Chemistry; Cyclohexanecarboxylic Acids; Dansyl Compounds; Enzyme Activation; Factor XIII; Fibrin; Fibrinolysis; Glutamine; Humans; Methylamines; Naphthalenes; Structure-Activity Relationship; Sulfonamides; Thrombosis; Transferases

1972